BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
Credit Suisse maintains neutral on Torrent Pharma
Nexium opportunity for Torrent is larger than anticipated. Higher market share can be sustained by Torrent. Every 5 per cent increase in market share adds 5 per cent to FY17 earnings per share estimates.